2017 annual financial data
Relmada Therapeutics 2017 Net income growth
Direct answer
Net income growth was -111.33%.
Operating income was -7,219,000 USD and net income was -6,287,000 USD.
Operating cash flow was -6,466,335 USD.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -7,219,000 USD
- Net income
- -6,287,000 USD
- Operating cash flow
- -6,466,335 USD